Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
Alsoud D, Moes DJAR, Wang Z, Soenen R, Layegh Z, Barclay M, Mizuno T, Minichmayr IK, Keizer RJ, Wicha SG, Wolbink G, Lambert J, Vermeire S, de Vries A, Papamichael K, Padullés-Zamora N, Dreesen E.
Alsoud D, et al. Among authors: wang z.
Ther Drug Monit. 2024 Apr 17. doi: 10.1097/FTD.0000000000001204. Online ahead of print.
Ther Drug Monit. 2024.
PMID: 38648666